Extracellular vesicles as markers for prostate cancer
Extracelluar vesicles can be used as markers for prostate cancer. The general idea is that patients with cancer will have a higher abundance of exosomes with CD9 and CD63, therefore if it would be possible to quantify the amount of these proteins, they would become a clear path to diagnosis.
One possible path is to combine TR-FIA with europium labeling[@duijvesz2015aImmuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer: Extracellular vesicles as marker for PCa]. An essay similar to Elisa tests with fluorescence is able to quantify the amount of CD9 and CD63 in urine samples from patients with and without prostate cancer.
These are the other notes that link to this one.